STOCK TITAN

Guardant Health (NASDAQ: GH) notice: proposed sale of 1,000 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Guardant Health lists a proposed sale of 1,000 shares of Common stock. The filing states the sale relates to a restricted stock lapse dated 10/17/2025 and is identified as equity compensation. The excerpt also shows past sales by Manuel Hidalgo Medina: 1,300 shares on 03/06/2026 for $118,997.00 and 1,250 shares on 05/20/2026 for $133,864.00.

Positive

  • None.

Negative

  • None.

Insights

Routine disclosure of a proposed resale tied to vested compensation and recent small insider sales.

The filing records a proposed sale of 1,000 shares following a restricted stock lapse dated 10/17/2025, labeled as equity compensation. This is a standard Form 144 notice that permits a broker or holder to sell shares under Rule 144 after vesting or lapse events.

Examples shown include two recent dispositions by Manuel Hidalgo Medina: 1,300 shares on 03/06/2026 for $118,997.00 and 1,250 shares on 05/20/2026 for $133,864.00. Cash‑flow treatment and broader position details are timing- and holder-specific in the excerpt.

Proposed resale 1,000 shares restricted stock lapse dated 10/17/2025
Sale by Manuel Hidalgo Medina 1,300 shares sold 03/06/2026 for $118,997.00
Sale by Manuel Hidalgo Medina 1,250 shares sold 05/20/2026 for $133,864.00
Form 144 regulatory
"Filer Information | | | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Restricted Stock Lapse financial
"Common | 10/17/2025 | Restricted Stock Lapse - See Remarks"
Equity Compensation financial
"1000 | 10/17/2025 | Equity Compensation"
Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Guardant Health's Form 144 for GH report?

It reports a proposed sale of 1,000 shares of Common stock tied to a restricted stock lapse dated 10/17/2025. The filing classifies the shares as equity compensation.

Who sold shares recently according to the excerpt for GH?

The excerpt lists sales by Manuel Hidalgo Medina: 1,300 shares sold on 03/06/2026 for $118,997.00 and 1,250 shares sold on 05/20/2026 for $133,864.00.

Does the Form 144 specify how the 1,000 shares will be sold?

The excerpt identifies the event as a restricted stock lapse and labels it equity compensation; specific methods of sale or broker instructions are not detailed in the provided excerpt.

Is the 1,000-share amount part of previously reported sales?

The filing shows the proposed 1,000-share resale separate from the two past dispositions by Manuel Hidalgo Medina on 03/06/2026 and 05/20/2026; the excerpt treats them as distinct entries.